Diasorin SpA (CHIX:DIAM) Interest Expense : €-16 Mil (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Diasorin SpA Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Diasorin SpA's interest expense for the three months ended in Dec. 2024 was € -4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-16 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Diasorin SpA's Operating Income for the three months ended in Dec. 2024 was € 68 Mil. Diasorin SpA's Interest Expense for the three months ended in Dec. 2024 was € -4 Mil. Diasorin SpA's Interest Coverage for the quarter that ended in Dec. 2024 was 17.00. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Diasorin SpA Interest Expense Historical Data

The historical data trend for Diasorin SpA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Interest Expense Chart

Diasorin SpA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-3.38

-22.51

-34.61

-29.34

-27.56

Diasorin SpA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-4.05	-4.00	-3.69	-4.00	-4.00

Diasorin SpA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-16 Mil.

Diasorin SpA (CHIX:DIAm) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Diasorin SpA's Interest Expense for the three months ended in Dec. 2024 was €-4 Mil. Its Operating Income for the three months ended in Dec. 2024 was €68 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was €967 Mil.

Diasorin SpA's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	68	/	-4
	=	17.00

The higher the ratio, the stronger the company's financial strength is.

Diasorin SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (CHIX:DIAm) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

DSRLF:USA DIA:Italy 0GZX:UK 34D:Germany DIAS:Austria

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines